We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+19.1%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$16.9B
AUM Growth
+$737M
Cap. Flow
-$219M
Cap. Flow %
-1.29%
Top 10 Hldgs %
56.42%
Holding
122
New
26
Increased
36
Reduced
29
Closed
20

Top Sells

Rank Stock Value
1
KDP icon
Keurig Dr Pepper
KDP
+$596M
2
XL
XL Group Ltd.
XL
+$407M
3
LOGM
LogMein, Inc.
LOGM
+$214M
4
GILD icon
Gilead Sciences
GILD
+$207M
5
IQV icon
IQVIA
IQV
+$126M

Sector Composition

Rank Sector Weight
1 Healthcare 24.15%
2 Technology 17.4%
3 Communication Services 12.66%
4 Financials 12.19%
5 Industrials 5.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
101
Biogen
BIIB
$30.5B
-249,000
Closed -$72.3M
CI icon
102
Cigna
CI
$72.7B
-671,000
Closed -$114M
FOLD
103
DELISTED
Amicus Therapeutics
FOLD
-3,655,000
Closed -$57.1M
GILD icon
104
Gilead Sciences
GILD
$162B
-2,920,000
Closed -$207M
KDP icon
105
Keurig Dr Pepper
KDP
$41.3B
-4,885,000
Closed -$596M
KNSA icon
106
Kiniksa Pharmaceuticals
KNSA
$5.97B
-114,589
Closed -$1.99M
KZR
107
DELISTED
Kezar Life Sciences
KZR
-7,667
Closed -$1.33M
SYBX
108
DELISTED
Synlogic
SYBX
-45,671
Closed -$6.73M
VEON icon
109
VEON
VEON
$3.87B
-40,000
Closed -$2.38M
XERS icon
110
Xeris Biopharma Holdings
XERS
$1.27B
-159,500
Closed -$3.03M
MOR
111
DELISTED
MorphoSys AG American Depositary Shares
MOR
-71,631
Closed -$2.17M
SURF
112
DELISTED
Surface Oncology, Inc. Common Stock
SURF
-100,000
Closed -$1.63M
IMMU
113
DELISTED
Immunomedics Inc
IMMU
-400,000
Closed -$9.47M
LOGM
114
DELISTED
LogMein, Inc.
LOGM
-2,074,072
Closed -$214M
PF
115
DELISTED
Pinnacle Foods, Inc.
PF
-145,000
Closed -$9.43M
ANDV
116
DELISTED
Andeavor
ANDV
-610,000
Closed -$80M
GGP
117
DELISTED
GGP Inc.
GGP
-5,085,000
Closed -$104M
CAVM
118
DELISTED
Cavium, Inc.
CAVM
-545,000
Closed -$47.1M
XL
119
DELISTED
XL Group Ltd.
XL
-7,272,500
Closed -$407M
HRG
120
DELISTED
HRG Group, Inc.
HRG
-2,290,000
Closed -$30M

Similar funds

Farallon Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Farallon Capital Management held 122 positions worth $16.9B, up 4.6% from $16.2B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Farallon Capital Management's Q3 2018 filing shows 26 new, 36 increased, 29 reduced and 20 closed positions. Its largest new stake was Equinix: 608,600 shares worth $263M. The largest sale was Keurig Dr Pepper, an estimated $596M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 20% a quarter earlier, followed by Technology and Communication Services.

  • Farallon Capital Management's largest Q3 2018 buy was Equinix: 608,600 shares worth $263M.
  • Farallon Capital Management added most to Express Scripts Holding Company in Q3 2018, an estimated $353M increase.
  • Farallon Capital Management's biggest Q3 2018 reduction was IQVIA, cutting an estimated $126M.
  • Farallon Capital Management fully exited Keurig Dr Pepper in Q3 2018, selling an estimated $596M.
  • Farallon Capital Management's ten largest holdings make up 56% of its $16.9B portfolio in Q3 2018.
  • Farallon Capital Management opened 26 new positions and closed 20 in Q3 2018.
  • Farallon Capital Management's portfolio value rose 4.6% quarter-over-quarter to $16.9B.

Based on Farallon Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.